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Introduction
The eukaryotic cell cycle is driven by a series of complexes com-
prising cyclins and Cdks. In budding yeast, cell cycle progression 
is controlled by a single Cdk, Cdc28, whose specificity is dictated 
by  its  cyclin  regulatory  subunit.  When  Cdk  forms  complexes 
with mitotic (M) cyclins (Clb1-4, with Clb2 being the prevalent 
species), the cells enter mitosis. For cells to exit from mitosis,   
S phase and M cyclins (collectively called Clbs) must be inacti-
vated (Morgan, 2007). In budding yeast, inactivation of Clb–Cdk 
is achieved by two redundant mechanisms (Donovan et al., 1994;   
Schwab et al., 1997; Visintin et al., 1997): (1) accumulation of 
the Clb–Cdk kinase inhibitor Sic1 (Mendenhall, 1993; Schwob   
et al., 1994) and (2) degradation of the Clb cyclins by a ubiquitin- 
dependent proteolysis machinery (Schwab et al., 1997; Visintin   
et al., 1997; Shirayama et al., 1998). The latter occurs in two steps. 
At anaphase onset, a specialized ubiquitin ligase known as the 
anaphase-promoting complex/cyclosome (APC/C), bound to its   
cofactor Cdc20 (APC/C
Cdc20), targets S phase and a subset of   
M cyclins for degradation by the proteosome. During late anaphase 
and the next G1, the APC/C in complex with Cdh1 (APC/C
Cdh1) 
contributes to the full removal of M cyclins (for review see   
Sullivan and Morgan, 2007). Besides Clb–Cdk inactivation, exit 
from mitosis requires the reversal of the phosphorylation events 
mediated by these kinases (for review see Sullivan and Morgan, 
2007). The conserved protein phosphatase Cdc14 plays a funda-
mental role in this process by both inactivating and reversing Clb–
Cdk activity (Jaspersen et al., 1998; Visintin et al., 1998; Zachariae 
et al., 1998; Jin et al., 2008). Cdc14 activity is negatively regu-
lated by Cfi1 (also known as Net1), which sequesters Cdc14 in the 
nucleolus from G1 up to metaphase (Shou et al., 1999; Visintin   
et al., 1999). The release of Cdc14 into the nucleus first and later 
into the cytoplasm responds to different cell cycle cues and is or-
chestrated in space and time by the interplay of two signal trans-
duction pathways known as Cdc fourteen early anaphase release 
(FEAR) and mitotic exit network (MEN; for review see Stegmeier 
and Amon, 2004). This sequential release of Cdc14 dictates the   
order of dephosphorylation of the multiple Clb–Cdk substrates 
(Jin et al., 2008), thereby establishing the correct execution of exit 
from mitosis (for reviews see Stegmeier and Amon, 2004; Rock 
and Amon, 2009).
At anaphase entry, the FEAR network initiates the release of 
Cdc14 from the nucleolus (Pereira et al., 2002; Stegmeier et al., 
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n  budding  yeast,  the  phosphatase  Cdc14  orchestrates 
progress through anaphase and mitotic exit, thereby re-
setting the cell cycle for a new round of cell division. Two 
consecutive pathways, Cdc fourteen early anaphase release 
(FEAR) and mitotic exit network (MEN), contribute to the pro-
gressive activation of Cdc14 by regulating its release from 
the nucleolus, where it is kept inactive by Cfi1. In this study, 
we show that Cdc14 activation requires the polo-like kinase 
Cdc5  together  with  either  Clb–cyclin-dependent  kinase   
(Cdk) or the MEN kinase Dbf2. Once active, Cdc14 trig-
gers a negative feedback loop that, in the presence of stable 
levels of mitotic cyclins, generates periodic cycles of Cdc14 
release and sequestration. Similar phenotypes have been 
described for yeast bud formation and centrosome duplica-
tion. A common theme emerges where events that must hap-
pen only once per cycle, although intrinsically capable of 
oscillations, are limited to one occurrence by the cyclin–Cdk 
cell cycle engine.
Oscillations in Cdc14 release and sequestration 
reveal a circuit underlying mitotic exit
Romilde Manzoni,
1 Francesca Montani,
2 Clara Visintin,
2 Fabrice Caudron,
3 Andrea Ciliberto,
1 and Rosella Visintin
2
1The Italian Foundation for Cancer Research (FIRC) Institute of Molecular Oncology, 20139 Milan, Italy
2Department of Experimental Oncology, European Institute of Oncology, 20139 Milan, Italy
3Department of Biology, Institute of Biochemistry, ETH Zurich, 8006 Zurich, Switzerland
©  2010  Manzoni  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 190 • NUMBER 2 • 2010   210
2008; Mohl et al., 2009). We aimed to evaluate what is the 
minimal kinase requirement capable of promoting the release 
of Cdc14. Because these kinases are all active during mitosis, 
we decided to minimize the side effects caused by their ectopic   
manipulation by analyzing them in G1 and S phase. In these 
phases of the cell cycle, both Clb2 and Cdc5 are absent or just 
start to accumulate (Morgan, 2007), MEN is inactive (for review 
see Stegmeier and Amon, 2004), and thus, Cdc14 is sequestered 
in the nucleolus (Shou et al., 1999; Visintin et al., 1999).
When cells are blocked in G1, neither overexpression of 
an allele of Cdc5 resistant to degradation (GAL-CDC5dB;   
Shirayama et al., 1998) nor overexpression of a hyperactive allele 
of Cdc15 (GAL-CDC15(1–750)), known to ectopically activate 
Dbf2 (Bardin et al., 2003; Visintin et al., 2003), was able to in-
duce the release of Cdc14. However, the combined expression of 
these alleles of Cdc5 and Cdc15 led to Cdc14 release (Fig. 1 a).   
To overexpress genes of interest, their open reading frame was 
placed under the control of the inducible GAL1-10 promoter.   
Because high levels of Clb2 quickly drive cells blocked in G1 into 
S phase (Morgan, 2007), the contribution of overexpressing Clb2 
was assessed directly in cells blocked in S phase. In this phase 
of the cell cycle, neither the overexpression of a nondegradable 
allele of Clb2 (GAL-CLB2dB; Fig. 1 b; Surana et al., 1993), 
of a hyperactive allele of Cdc15, nor the combined overexpres-
sion of these alleles of Clb2 and Cdc15 induced Cdc14 release 
(Fig. 1 c). Different than in G1, ectopic expression of Cdc5 in 
S phase–arrested cells was able to trigger Cdc14 release (Fig. 1, 
b and c; Visintin et al., 2003), but it did so in a Cdk-dependent 
manner, as shown by the lack of release when the cdc28-as1 ATP 
analogue–sensitive allele of Cdc28 (Bishop et al., 2001) was in-
hibited (Fig. 1 b). As for cells arrested in G1, the concomitant 
activation of Cdc5 and MEN rendered the presence of Clb–Cdk 
dispensable (Fig. 1 c). Our results show that Cdc14 is released 
from the nucleolus via a two-hit mechanism, which requires the 
combined activity of two different kinases, Cdc5 and either MEN 
kinase Dbf2 or Clb–Cdk.
Nondegradable Clb2 is not sufficient  
to maintain Cdc14 released in the  
absence of MEN
The observation that Cdc5 requires Clb–Cdk or MEN activity   
to release Cdc14 in phases other than anaphase suggests an   
appealing interpretation to explain how the correct timing of 
Cdc14 activation is achieved during a normal cell cycle. At ana-
phase onset, Cdc5 and Clb2–Cdk would be responsible to initi-
ate Cdc14 release. At this stage, although Cdc5 and Clb2–Cdk 
are active, MEN is not (for review see Stegmeier and Amon, 
2004). During mid- to late anaphase, MEN becomes activated 
(for review see Stegmeier and Amon, 2004) concomitantly with 
the reduction of Clb2 levels triggered by the APC/C
Cdc20 (Morgan, 
2007). Thus, it can maintain Cdc14 in its released state by   
taking over the role of Clb2–Cdk when the activity of the latter 
goes below a critical threshold. This mechanism would also   
explain Cdc14 dynamics in mutants lacking MEN, which is in 
agreement with a previously proposed model (Queralt et al., 
2006). FEAR and MEN are not redundant; in MEN mutants,   
the release of Cdc14 brought about by the FEAR network is 
2002; Yoshida and Toh-e, 2002). The activation of this signaling 
cascade is triggered by the APC/C
Cdc20 that targets for the degrada-
tion of securin, thereby activating separase, an element of FEAR 
(for review see Stegmeier and Amon, 2004). Via a series of re-
actions that still need to be fully understood, separase activation 
eventually leads to the Clb2–Cdk-dependent phosphorylation of 
Cfi1, which results in the dissociation of Cdc14 from its inhibitor 
and movement of the phosphatase into the nucleus (Azzam et al., 
2004; Queralt et al., 2006). Although FEAR initiates Cdc14 re-
lease, it is the MEN pathway that contributes to the full activation 
of Cdc14 by maintaining it released and allowing its accumulation 
into the cytoplasm (Shou et al., 1999; Visintin et al., 1999; Mohl   
et al., 2009). To date, the most downstream component of the MEN 
is the protein kinase Dbf2 (for review see Stegmeier and Amon, 
2004) and is therefore considered the MEN effector. As soon as 
exit from mitosis is completed, Cdc14 is quickly resequestered 
into the nucleolus (Shou et al., 1999; Visintin et al., 1999).
Central to the regulation of Cdc14 is the polo-like kinase 
Cdc5. Cdc5 belongs to both the FEAR network (Pereira et al., 
2002; Stegmeier et al., 2002; Visintin et al., 2008) and MEN   
(Hu et al., 2001; Hu and Elledge, 2002; Geymonat et al., 2003). It 
is also the only protein among the FEAR and MEN network com-
ponents that, when overexpressed, can promote the release of 
Cdc14 from the nucleolus in stages other than anaphase (Visintin 
et al., 2003). The importance of Cdc5 in releasing Cdc14 is also 
underscored by the observation that its depletion is necessary and 
sufficient for the return of the phosphatase into the nucleolus 
(Visintin et al., 2008).
A common theme of the networks controlling Cdc14   
localization is the role played by kinases. The polo-like kinase 
Cdc5, Clb2–Cdk, and likely the MEN kinase Dbf2 all converge 
to promote Cdc14 release (Hu et al., 2001; Hu and Elledge, 2002; 
Pereira et al., 2002; Stegmeier et al., 2002; Yoshida and Toh-e, 
2002; Geymonat et al., 2003; Visintin et al., 2003, 2008; Azzam 
et al., 2004; Queralt et al., 2006; Mohl et al., 2009). How the three 
kinases interact to induce a timely and complete release of Cdc14 
is unknown. In this study, we addressed this question by modulat-
ing the activity of these kinases either alone or in mutual combi-
nation at various cell cycle stages. We found that the combination 
of Cdc5 with either Clb–Cdk or Dbf2 is necessary and sufficient 
to promote Cdc14 release from the nucleolus. Our results provide 
an explanation of how the interplay of the aforementioned kinases 
results in the release of Cdc14 at the right time of the cell cycle. 
Once fully released, Cdc14 triggers a negative feedback loop that, 
in the presence of stable levels of M cyclins, gives rise to peri-
odic cycles of Cdc14 release and sequestration. Similar oscilla-
tory phenotypes have been described for yeast bud formation and 
centrosome duplication, suggesting a paradigm whereby events 
capable of repeating themselves multiple times are restrained to 
occur once per cycle by their coupling to the cyclin–Cdk engine.
Results
Cdc5 and either Clb–Cdk or the MEN are 
required for Cdc14 release
Three kinases control Cdc14 release from the nucleolus, Cdc5, 
Clb2–Cdk, and the MEN kinase Dbf2 (Queralt and Uhlmann, 211 The mitotic exit oscillator at work • Manzoni et al.
release, resembling the one mediated by MEN (compare Fig. 3 b 
[135 min] with Fig. 2, c and d). However, this shift toward a 
MEN-type release was incomplete, suggesting that Clb2–Cdk 
expressed at high doses and MEN have overlapping but not 
identical roles. This conclusion is consistent with recent results 
showing that Cdc14 accumulation in the cytoplasm is medi-
ated by phosphorylation of Cdc14 by Dbf2 (Mohl et al., 2009). 
When nondegradable Clb2 was expressed at low doses, Cdc14 
localization dynamics remained similar to that observed in an 
MEN single mutant for both the small fraction of anaphase 
cells with Cdc14 released (Fig. 3 c) and the nuclear localization   
(unpublished data).
Regardless of the presence of nondegradable Clb2, Cdc14 
eventually reentered the nucleolus in both cases. Although with 
low doses it remained there, after some time with high doses, 
Cdc14 was surprisingly released again. Noticeably, the alter-
nation of sequestration and release of Cdc14 was not an isolated 
event but occurred three to four times during the 5 h of observa-
tion (Fig. 3 a), and during each cycle, Cdc14 was always fully 
released into the cytoplasm (Fig. 3 b; and Videos 1 and 2).   
In conclusion, our data suggest that the stabilization of Clb2 is 
not sufficient to maintain Cdc14 released in MEN mutants.
Clb–Cdk stabilization maintains Cdc14 
released in the absence of MEN
If in MEN mutants, Cdc14 is sequestered even in the presence 
of  stable  Clb2,  what  other  mechanisms  contribute  to  Cdc14 
sequestration? We aimed to verify whether other Clbs besides 
Clb2 could play a role in this process. This hypothesis is con-
sistent with the results of our experiments in cells arrested in   
S phase, where Cdc5 requires Clb–Cdk activity to release Cdc14   
(Fig. 1 b), as by inactivating Cdc28 directly, we inhibited all 
Clb–Cdk complexes at once. To test whether stabilization of 
Clbs other than Clb2 can maintain Cdc14 released in MEN mu-
tants, we stabilized all Clbs at physiological levels by depleting   
transient and limited to the nucleus and is thus insufficient to 
complete exit from mitosis (Fig. 2, a and c; Pereira et al., 2002; 
Stegmeier et al., 2002; Yoshida and Toh-e, 2002). In this study, 
we will refer to this phenotype as the FEAR phenotype. Only by 
the additional contribution of MEN can the release of Cdc14 be 
prolonged in time, resulting in Cdc14 spreading into the cyto-
plasm as well (Fig. 2, b and d; Mohl et al., 2009; for review see 
Stegmeier and Amon, 2004). According to this model, the de-
crease of Clb2–Cdk activity is not compensated in MEN mu-
tants and might be the reason why the FEAR-mediated Cdc14 
release is transient.
If this hypothesis is correct, it should be possible to make 
Cdc14 release permanent even in the absence of MEN by sta-
bilizing Clb2. To test this hypothesis, we tracked the kinetic of 
Cdc14 localization in a synchronous population of cells over-
expressing  a  nondegradable  form  of  Clb2  (GAL-CLB2dB) 
while being impaired in MEN because of the ATP analogue–
sensitive allele of CDC15 (cdc15-as1; Bishop et al., 2001). 
We expressed Clb2dB at low and high doses to cover a wide 
range of Clb2 concentrations. As for the low doses, we first 
determined the minimal galactose concentration necessary to 
arrest the cells in mitosis. GAL-CLB2dB cells exit from mito-
sis when grown in media with 0.025% galactose (unpublished 
data) but are blocked in the presence of 0.05% galactose. Thus, 
we grew GAL-CLB2dB cdc15-as1 cells in 0.05% galactose 
to express what we call low doses of nondegradable Clb2. For 
the high doses, we used 1% galactose. Nucleolar integrity was 
assessed by imaging the nucleolar protein Nop1 (Fig. S1 a; 
Tollervey et al., 1991).
In the presence of nondegradable Clb2 expressed at high 
doses, more cdc15-as1 mutant cells released Cdc14 as com-
pared with the cdc15-as1 single mutant (compare the release 
at 135 min in Fig. 3 a with the release at 105 min in Fig. 2 a).   
Interestingly, we noticed that the spatial pattern of Cdc14 release 
changed from a nuclear FEAR type to a nuclear and cytoplasmic   
Figure 1.  Cdc5 requires a partner kinase for promoting Cdc14 release. (a) GAL-CDC5dB (Ry1358; GAL-CDC5N70), GAL-CDC15(1–750) (Ry995), 
and GAL-CDC5dB GAL-CDC15(1–750) (Ry1345) cells were arrested in G1 by -factor in YEPR. When arrest was complete, the media were supple-
mented with 2% galactose to induce the expression of CDC5dB and CDC15(1–750). The percentage of cells with Cdc14 released from the nucleolus 
was determined at the indicated times. (b) GAL-CDC5dB (Ry1358), GAL-CLB2dB (Ry448), and GAL-CDC5dB cdc28-as1 (Ry1356) cells were arrested 
in G1 with -factor in YEPR and released in YEPR fresh media supplemented with HU to induce a synchronous arrest in S phase. Once cells were arrested, 
the media were supplemented with 2% galactose to induce the expression of CDC5dB and CLB2dB together with the Cdc28-as1 inhibitor (1NM-PP1 
analogue 9; Bishop et al., 2001). Cell samples were analyzed as in a. (c) GAL-CDC5dB (Ry1358), GAL-CDC15(1–750) (Ry995), GAL-CDC5dB 
GAL-CDC15(1–750) (Ry1345), GAL-CDC5dB GAL-CDC15(1–750) cdc28-as1 (Ry1353), and GAL-CLB2dB GAL-CDC15(1–750) (Ry1547) cells were 
treated and analyzed as described in b.JCB • VOLUME 190 • NUMBER 2 • 2010   212
As Clb5 is the predominant species among S phase cyclins 
and it is degraded at the metaphase to anaphase transition (Fig. 2, 
e and f), we set to verify its contribution to Cdc14 release in the 
absence of MEN. To this aim, we analyzed the consequences   
of deleting CLB5 in a MET-CDC20 pds1 cdc15-as1 mutant. 
To our surprise, in this mutant, we found that Cdc14 was never 
released from the nucleolus (Fig. 4 c). This result points to Clb5 
as a novel member of the FEAR pathway. Indeed, the pattern 
of Cdc14 release of the MET-CDC20 pds1 cdc15-as1 clb5  
mutant in the absence of the Cdc15 inhibitor, and thus with   
Cdc20 in a strain lacking PDS1 (Cdc20 depletion was achieved 
by  repressing  transcription  of  CDC20  from  the  methionine-
repressible  MET3  promoter  MET-CDC20  pds1;  Fig.  S2  a; 
Mountain  and  Korch,  1991). These  cells  arrest  in  telophase 
with Cdc14 released (Fig. 4 a; Shirayama et al., 1999). Strik-
ingly, the same phenotype was observed when we inactivated 
MEN via the cdc15-as1 allele (Fig. 4, compare b with e;   
and Fig. S2 b). These results indicate that degradation of other 
Clbs besides Clb2 is the reason why Cdc14 is resequestered in 
MEN mutants.
Figure 2.  Cdc14 localization and Cdc5 degradation in wild-type cells and MEN mutants. (a–f) cdc15-as1 (Ry1132; a, c, and e) and wild-type (Ry278; 
b, d, and f) cells were arrested in G1 with -factor in YEPD at 23°C and released in fresh YEPD media supplemented with the Cdc15-as1 inhibitor (1NM-PP1 
analogue 9; Bishop et al., 2001). (a and b) At the indicated time points, samples were taken to determine the percentages of metaphase spindles (closed 
squares), anaphase spindles (closed circles), and cells with Cdc14 released from the nucleolus (open circles). Examples of Cdc14 localization for the 105-min 
time point are shown. (c and d) Cdc14 is shown in red, tubulin in green, and DAPI in blue. Bars, 3 µm. (e and f) For the entire time course, we analyzed 
Clb5, Clb2, Cdc5, and Pgk1 protein levels. Pgk1 protein was used as an internal loading control in immunoblots. Black lines indicate that intervening lanes 
have been spliced out. Size markers on the sides of the gel blots indicate kilodaltons.213 The mitotic exit oscillator at work • Manzoni et al.
cycles of Cdc14 release and sequestration. Therefore, what is 
the molecular circuit underlying the oscillatory behavior? First, 
we asked whether the aforementioned kinase requirement for 
Cdc14 release (i.e., the two-hit hypothesis whereby Cdc5 and 
either MEN or Clb–Cdk are necessary for Cdc14 release) was 
satisfied during the oscillations. According to this model, oscil-
lations (a) should persist in the presence of at least one between 
MEN and Clb2–Cdk, (b) should be abolished by the simultane-
ous removal of both MEN and Clb2–Cdk, (c) should occur 
when both are present, and (d) should be abolished by the   
inactivation of Cdc5.
Thus, we moved to test the predictions. We have already 
shown that high doses of Clb2–Cdk can sustain oscillations in 
the absence of MEN (Fig. 3 a). To test whether MEN alone 
can drive the oscillations, we interfered with Clb2–Cdk ability 
to release Cdc14 by using an allele of Cfi1 (cfi1-6Cdk) lack-
ing six Clb2–Cdk phosphorylation sites. This mutant releases 
Cdc14 with the kinetic typical of FEAR mutants (Azzam et al., 
2004). In agreement with our prediction, we found that in the 
presence of high doses of stable Clb2, in the cfi1-6Cdk mutant 
cells, although Cdc14 was released with a delay, oscillations 
active MEN, closely resembles the typical phenotype of FEAR 
mutants (Fig. 4 d) in which Cdc14 release is delayed during early 
anaphase. We conclude that the stabilization of both S phase and   
M cyclins is sufficient to render full and stable the release of Cdc14. 
This result is consistent with the hypothesis that S phase cyclin 
degradation contributes to Cdc14 sequestration.
Oscillations are impaired in Cdc5 mutants 
and in the absence of both MEN- and  
Clb2–Cdk-mediated phosphorylation of Cfi1
Although Cdc14 was resequestered in the presence of both high 
and low doses of nondegradable Clb2, oscillations arose only in 
cells blocked in anaphase by high doses. In this setting, it is also 
possible that Clb5 is required for Cdc14 release and, accord-
ingly, that the first sequestration event is related with its degra-
dation. However, at the metaphase to anaphase transition, the 
APC/C
Cdc20 is activated, and thus, it is unlikely that Clb5 is pres-
ent during the ensuing cycles of Cdc14 release and sequestra-
tion. In this setting, we can hypothesize that in MEN mutants, 
high doses of nondegradable Clb2 can make up for the lack of 
Clb5 and trigger an additional mechanism that leads to multiple 
Figure 3.  Nondegradable Clb2 promotes periodic cycles of Cdc14 release and sequestration. (a and b) GAL-CLB2dB cdc15-as1 (Ry1394) cells were 
arrested with -factor in YEPR and released into medium supplemented with 1% galactose and 5 µM 1NM-PP1 analogue 9 (Bishop et al., 2001) to induce 
the expression of Clb2 and inactivate the cdc15-as1 allele, respectively. (a) The percentages of cells with metaphase spindles (closed squares), anaphase 
spindles (closed circles), and cells with Cdc14 released from the nucleolus (open circles) were determined at the indicated times. (b) The localization 
of Cdc14 and the morphology of the mitotic spindle and nuclei for representative fields of cells are shown for various time points (Videos 1 and 2).   
Bar, 3 µm. (c) GAL-CLB2dB cdc15-as1 (Ry1394) cells were arrested with -factor in YEPR and released into fresh medium supplemented with 0.05% 
galactose and 5 µM Cdc15-as1 inhibitor (1NM-PP1 analogue 9; Bishop et al., 2001). Cell samples were analyzed as in a.JCB • VOLUME 190 • NUMBER 2 • 2010   214
The  prediction  was  confirmed  experimentally  by  using  the 
temperature-sensitive mutant cdc5-1 with no distinction be-
tween high and low doses (Fig. 5, f and g). The resequestration 
of Cdc14 was not a mere consequence of the temperature shift 
because the GAL-CLB2dB single-mutant strain shows oscil-
lations at 37°C as well (Fig. S2 c). In conclusion, our data sug-
gest that the periodical release and sequestration of Cdc14 is in 
agreement with the kinase requirement as proposed by the two-
hit model.
Cdc14 oscillations require Cdc5,  
Cdc14, and Cdh1
The simultaneous inactivation of either MEN and Clb2–Cdk or 
Cdc5 interfered with the oscillatory phenotype. Thus, we set 
out to understand which of these two activities is periodically 
regulated during the oscillations. The simultaneous and co-
ordinated activation and inactivation of Clb2–Cdk and MEN is 
difficult to envision. A much easier option is that oscillations 
are driven by regulation of the polo-like kinase Cdc5. At the 
end of mitosis, Cdc5 is negatively regulated by a negative feed-
back loop composed of Cdc5, Cdc14, and APC/C
Cdh1 (Visintin 
et al., 2008). In this setting, Cdc14 induces the activation of   
APC/C
Cdh1, which leads to Cdc5 degradation and, thus, to 
Cdc14 resequestration. Noticeably, theoretical studies proved 
nevertheless  arose  (Fig.  5  a). The  simultaneous  removal  of 
both MEN and Clb2–Cdk can arrest the oscillatory behavior, 
as observed when cdc15-as1 was inhibited with the analogue-
sensitive  inhibitor  in  combination  with  the  cfi1-6Cdk  allele 
both when the inhibitor was added before or after the initial 
release (Fig. 5, b and c). Finally, we confirmed that oscillations 
arise when both MEN and Clb2–Cdk are present (Fig. 5 d). 
So far, we have observed oscillations only in the presence of 
high levels of stabilized Clb2. Given that both Clb2–Cdk and 
MEN alone can sustain the oscillations, we asked whether the 
presence of MEN would allow low levels of stable Clb2–Cdk 
to undergo periodical cycles of Cdc14 release and resequestra-
tion, and we found this to be the case (Fig. 5 e). Because the 
release of Cdc14 in the simultaneous presence of Clb2–Cdk 
and MEN resembles that observed in wild-type cells (Fig. S1, 
b and c), we decided to investigate the molecular nature of the 
oscillations in this setting, using both high and low doses of 
nondegradable Clb2.
The final prediction of the two-hit model is that Cdc5 is 
required to generate oscillations. If this is the case, then a loss 
of function allele of CDC5 should sequester Cdc14 without 
further release. Because Cdc5 is required for the release of 
Cdc14, the allele was inactivated after a large fraction of the 
population had reached anaphase (as assessed by DAPI staining). 
Figure  4.  Stabilization  of  S  and  M  phase 
cyclins  leads  to  constant  Cdc14  release.  
(a–e) MET-CDC20 pds1 cdc15-as1 (Ry1558; 
a and b), MET-CDC20 pds1 cdc15-as1 clb5 
(Ry1538; c and d), and cdc15-as1 (Ry1132; e) 
cells were arrested in G1 with -factor in a 
synthetic complete medium lacking methionine. 
When arrest was complete, cells were released 
into YEPD media lacking the pheromone but 
with  an  added  8  mM  methionine  to  repress 
the expression of Cdc20 in the presence (b, c, 
and e) or absence (a and d) of 5 µM Cdc15-
as1 inhibitor (1NM-PP1 analogue 9; Bishop   
et  al.,  2001).  The  percentages  of  cells  with 
metaphase spindles (closed squares), anaphase 
spindles (closed circles), and cells with Cdc14 
released from the nucleolus (open circles) were 
determined  at  the  indicated  times.  The  pres-
ence or absence of the inhibitor is indicated   
as + or , respectively.215 The mitotic exit oscillator at work • Manzoni et al.
permissive temperature with the de novo protein synthesis inhib-
ited by cycloheximide, and (2) we asked whether in the presence 
of a wild-type copy of CDC14 the Cdc14-1–6HA mutant protein 
could bind Cfi1 at the restrictive temperature. We found that the 
cdc14-1 arrest is reversible (Fig. S3 a), and the mutant Cdc14-1– 
6HA protein in a heterozygous diploid  CDC14/cdc14-1–6HA 
strain undergoes a wild-type kinetic of release and sequestration   
at the restrictive temperature after release from an S phase arrest 
(Fig. S3, b and c). We concluded that in our experimental setup, 
Cdc14-1 stays released because it is enzymatically inactive.
In the negative feedback loop, Cdc14 induces its own se-
questration by indirectly destabilizing Cdc5. If the loop works 
as expected, we predict that stabilizing Cdc5 should abolish the 
oscillations. We tested this possibility using a nondegradable 
mutant of Cdc5 (Visintin et al., 2008), and indeed, in this set-
ting, Cdc14 was always in a released state for both high and 
low doses (Fig. 6, c and d). Although it is possible that other 
that the minimal circuit capable of oscillations is a negative 
feedback loop composed by three elements (Novák and Tyson, 
2008). Thus, we set to verify whether this is the circuit under-
lying the oscillatory behavior.
If Cdc14 belongs to the loop and is required for its own 
resequestration,  as  recently  proposed  (Visintin  et  al.,  2008; 
Tomson et al., 2009), the prediction is that in a Cdc14 loss of 
function mutant, the loop cannot be closed, and Cdc14 should 
always  be  released.  We  tested  this  hypothesis  using  the 
temperature-sensitive  cdc14-1  mutant  and  found  the  pre-
diction to be true for both high and low doses (Fig. 6, a and b).   
A possible caveat to this experiment is that the mutant protein 
at the restrictive temperature could be misfolded and thus un-
able to bind its inhibitor. In this case, we would observe Cdc14 
constantly released independently from Cdc5 stabilization. We 
tackled this problem in two ways: (1) we assessed whether the 
cdc14-1 arrest was reversible once cells were shifted back to the 
Figure  5.  Cdc14  oscillations  fulfill  the  kinase   
requirement of the two-hit model. (a) GAL- 
CLB2dB cfi1-6Cdk (Ry1545) cells were ar-
rested with -factor in YEPR and released into   
medium  supplemented  with  1%  galactose  to   
induce  the  expression  of  Clb2.  The  percent-
ages of cells with metaphase spindles (closed 
squares), anaphase spindles (closed circles), 
and cells with Cdc14 released from the nucle-
olus  (open  circles)  were  determined  at  the 
indicated  times.  (b  and  c)  GAL-CLB2dB 
cfi1-6Cdk cdc15-as1 (Ry1715) cells were ar-
rested with -factor in YEPR and released into   
medium  supplemented  with  1%  galactose.   
195 min into the release (b) or at the moment 
of the release (c), 5 µM 1NM-PP1 analogue   
9 inhibitor (Bishop et al., 2001) was added to 
inactivate the cdc15-as1 allele. Cell samples 
were analyzed as in a. (d and e) GAL-CLB2dB 
(Ry430)  cells  were  arrested  in  G1  with   
-factor in YEPR and released into fresh me-
dium supplemented with 1 (d) or 0.05% (e) ga-
lactose. Cell samples were analyzed as in a.   
(f  and  g)  GAL-CLB2dB  cdc5-1  (Ry1393) 
cells were treated as in d and e, respectively. 
Cells were shifted at the restrictive temperature   
165 min after the release. Cell samples were 
analyzed as in a. Arrows indicate the time of 
inhibitor addition in b (+In) and the shift to the 
restrictive temperature in f and g.JCB • VOLUME 190 • NUMBER 2 • 2010   216
of poor synchronization and, thus, the result of an averaging of 
the oscillations observed at the population level. However, this 
possibility is unlikely because wild-type cells released from a 
metaphase arrest induced by nocodazole, although poorly syn-
chronous, show oscillations, whereas the cdh1 mutant con-
firmed the intermediate phenotype (Fig. S2, e and f). Thus, we 
decided to further assess the contribution of degradation to the 
oscillatory behavior by analyzing the pattern of Cdc14 localiza-
tion in cells carrying a temperature-sensitive allele of CDC23 
(cdc23-1), a core component of the APC/C (for review see   
Peters, 2006). Because APC/C is required for the metaphase to 
anaphase transition, the allele was inactivated after a large frac-
tion of the population had reached anaphase. In these cells, both 
at high and low doses of Clb2dB, Cdc14 does not oscillate, 
but, contrarily to cdh1, it is released in the entire anaphase 
population (Fig. 7, a and b), which is in agreement with the pos-
sibility that APC/C-dependent degradation of Cdc5 promoted 
by Cdc14 is required for the oscillatory behavior. We confirmed 
the role of protein synthesis and degradation in the generation 
of oscillations by blocking protein synthesis with cyclohexi-
mide 180 min after having overexpressed nondegradable Clb2. 
In these conditions, Cdc14 was sequestered and never released 
(Fig. S2 d). Moreover, we observed a reduction of Cdc5 levels 
in the presence of high levels of stabilized Clb2 with live cell 
mechanisms such as the effect of opposing phosphatases might 
also contribute to modulate Cdc5 activity, the result is in agree-
ment with the notion that the negative regulation occurs via 
Cdc5 degradation. This is not obvious, as in the presence of 
high levels of Clb2, APC/C
Cdh1 should be inhibited (for review 
see Peters, 2006). This possibility, however, allows a clear pre-
diction: in a cdh1 strain, oscillations should be lost and Cdc14 
fully  released. We  tested  this  prediction  and  confirmed  that   
oscillations were indeed lost, which is a result confirmed for 
both high and low doses (Fig. 6, e and f).
APC/C
Cdh1 is not the only form of APC/C 
capable of degrading Cdc5
The oscillatory phenotype observed in the cdh1 mutant only 
partially confirmed the prediction; indeed, Cdc14 localization 
in anaphase cells was intermediate in nature. In cells with high 
doses of nondegradable Clb2, approximately half of the cells 
showed Cdc14 released, whereas the other half showed Cdc14 
sequestered (Fig. 6 e). Cells with low doses of Clb2 also had an 
intermediate phenotype, but in these conditions, >50% of ana-
phase cells had Cdc14 released (Fig. 6 f). The reasons for this 
discrepancy are at the moment unclear. Because cdh1 cells 
are difficult to arrest in G1 (Schwab et al., 1997), we reasoned 
that such an intermediate phenotype could be a consequence 
Figure  6.  Mutants  that  interfere  with  the   
oscillatory behavior. (a and b) GAL-CLB2dB 
cdc14-1 (1575) cells were arrested with -factor 
in  YEPR  and  released  into  medium  supple-
mented with 1 (a) or 0.05% (b) galactose 
to induce the expression of Clb2. (a) The per-
centages  of  cells  with  metaphase  spindles 
(closed  squares),  anaphase  spindles  (closed 
circles), and cells with Cdc14 released from 
the nucleolus (open circles) were determined 
at  the  indicated  times.  Arrows  indicate  the   
time  of  the  temperature  shift  (180  min).   
(c and d) GAL-CLB2dB CDC5dB (Ry1392) 
cells were treated as in a and b, respectively. 
(e  and  f)  GAL-CLB2dB  cdh1  (Ry1466) 
cells were treated as in a and b, respectively.   
(c–f) Cell samples were analyzed as in a.217 The mitotic exit oscillator at work • Manzoni et al.
and the underlying molecular circuitry described in this study 
were also observed in the laboratory of F. Cross using live cell 
imaging (Lu and Cross, 2010).
Simulations point to an additional role  
for Cdc14
Our results show that cdc23-1 (Fig. 7, a and b) and cdc14-1  
(Fig. 6, a and b) mutants share the same phenotype, having   
Cdc14  permanently  released,  contrarily  to  cdh1  (Fig.  6,   
e and f), where Cdc14 is only partially released. The fact that 
cdh1 and cdc14-1 show different phenotypes is not consistent 
with the network we have analyzed so far (Cdc14 → Cdh1 
Cdc5 → Cdc14), in which the only role played by Cdc14 is to 
activate Cdh1. This discrepancy suggests that Cdc14 performs 
additional roles to induce its own sequestration. Given that both 
the inactivation of Cdc14 and APC/C (i.e., cdc23-1) cause the 
complete release of Cdc14, one possibility is that the cdc14-1 
mutant stabilizes Cdc5 as efficiently as the cdc23-1 mutant. We 
can envision one scenario (the Cdc5 stabilization hypothesis) 
whereby Cdc5 can be stabilized by phosphorylation (possibly 
by  Clb2–Cdk),  whereas  its  dephosphorylation,  catalyzed  by 
Cdc14, makes the kinase a good substrate for both APC/C
Cdc20 
and APC/C
Cdh1. Alternatively, the different phenotypes of cdh1 
and  cdc14-1  could  be  explained  if  Cdc14  would  induce  its   
own sequestration, besides triggering Cdc5 degradation, via de-
phosphorylating other substrates, a likely candidate being Cfi1 
(the Cfi1 dephosphorylation hypothesis). A detailed description 
of the Cfi1 dephosphorylation hypothesis is given in Fig. S4 a, 
whereas the molecular details of the Cdc5 stabilization hypoth-
esis are shown in Fig. S5 a.
We then set out to verify whether any of these two hypoth-
eses can account for all the results presented so far. Given the 
complexity of the aforementioned proposed circuits, we pre-
ferred to analyze them with the help of mathematical analysis. 
imaging (Videos 3 and 4). These results prompted us to verify 
whether the periodic release of Cdc14 was affected by Cdc20, 
the other cofactor of the APC/C (for review see Peters, 2006). 
When CLB2dB was overexpressed in a cdc20-3 mutant, we 
observed periodic sequestration and release of Cdc14 regard-
less of the expression levels of nondegradable Clb2 (Fig. 7,   
c and d), thus showing that Cdc20 is not implicated in the oscil-
latory loop. This result, together with what we observed in the 
cdc23-1 and cdh1 mutants, strongly points to a role for Cdh1 
in the generation of oscillations. This finding raises the possibil-
ity that the spatial localization of the components of this circuit 
allows Cdc14 to activate a subset of Cdh1 even in the presence 
of high levels of Clb2–Cdk.
As for the distribution of Cdc14 in cdh1 cells, we 
hypothesize that although in this strain Cdc5 is degraded in   
an APC-dependent manner, the negative feedback loop is de-
stroyed, and thus, oscillations are lost. In this context, Cdc5 
synthesis (Clb2–Cdk dependent; Darieva et al., 2003) and Cdc5 
degradation (APC dependent; for review see Peters, 2002) find 
an equilibrium. This intermediate value of Cdc5 could result 
in some cells having Cdc14 sequestered and others released. 
As for the APC-dependent and Cdh1-independent mechanism 
that drives Cdc5 degradation, our results hint to a possible 
role for Cdc20. In cdc15-as1 cells, APC/C
Cdh1 is not activated   
because Cdc14 is only transiently released from the nucleolus 
early in anaphase, and thus, Cdc20, a substrate of APC/C
Cdh1, 
is stabilized. In this setting, Cdc5 levels decrease with the same 
kinetics as Clb2 (Fig. 2, e and f), suggesting that similarly to 
Clb2, Cdc5 could also be partially degraded in an APC/C
Cdc20-
dependent manner.
In conclusion, the oscillations in Cdc14 localization are 
driven by the negative feedback loop, which includes Cdc14, 
Cdh1, and Cdc5 and controls Cdc14 relocalization at the end of 
mitosis (Visintin et al., 2008). The novel oscillatory phenotype 
Figure  7.  APC/C-dependent  degradation 
closes the loop. (a–d) GAL-CLB2dB cdc23-1 
(Ry1452; a and b) and GAL-CLB2dB cdc20-3  
(Ry1457; c and d) cells were arrested with   
-factor in YEPR and released into fresh me-
dium supplemented with 1 (a and c) or 0.05% 
(b and d) galactose to induce the expression of 
Clb2. Cells were shifted at the restrictive tem-
perature 180 min after the release (arrows).   
The percentages of cells with metaphase spindles 
(closed  squares),  anaphase  spindles  (closed 
circles), and cells with Cdc14 released from 
the nucleolus (open circles) were determined 
at the indicated times.JCB • VOLUME 190 • NUMBER 2 • 2010   218
What are the molecular implications of the two-hit model? 
The observation that the activity of Cdc5 is always required for 
Cdc14 release offers an appealing answer to this question. Polo-
like kinases, of which Cdc5 is the only yeast member, contain 
in their C terminus a conserved sequence motif called the polo 
box domain (PBD; Lee et al., 1998, 1999; Elia et al., 2003a). 
PBD mediates the interaction between the kinase and its sub-
strates after they have undergone phosphopriming by another 
kinase (Elia et al., 2003b). Therefore, we speculate that priming 
by Clb–Cdk and Dbf2 serves to build up Cdc5 activity. Cdc5 
phosphorylation of Cfi1 and/or of Cdc14 could then promote 
the release of Cdc14 from Cfi1. The validation of this hypoth-
esis awaits the identification of residues in Cdc14 and/or Cfi1 
whose phosphorylation status is cell cycle regulated. Of par-
ticular interest will be the identification of those residues that 
are specifically phosphorylated during anaphase, the cell cycle 
stage  during  which  the  Cdc14/Cfi1  interaction  is  disrupted.   
In support of this idea, six Clb2–Cdk-dependent phospho-
residues have been identified in Cfi1. Cells carrying a mutant allele   
of Cfi1 in which these amino acids have been mutated into alanine 
(cfi1-6Cdk), mimicking lack of phosphorylation, are delayed in 
the release of Cdc14. Notably, one of these residues (threonine 
212) is part of an optimal phosphobinding motif recognized by 
PBD (Elia et al., 2003a). Recently, we identified another residue 
in Cfi1, specifically phosphorylated during anaphase that lies in 
a putative Dbf2 recognition sequence (Mah et al., 2005) and is 
also part of a minimal PBD-phosphobinding motif (Elia et al., 
2003a; unpublished data). The consequences of mutating the 
latter residue into alanine will be a matter of further studies. 
As for the role of Clb5, the observation that recombinant Cfi1 
is phosphorylated in vitro by Clb2–Cdk but not by Clb5–Cdk 
(Azzam et al., 2004) argues against the two Clbs sharing the 
same function. Understanding how Clb5 impinges on the FEAR 
network will be an important quest for the future.
A model for Cdc14 dynamics at the exit 
from mitosis
We challenged the two-hit model by analyzing Cdc14 local-
ization in the presence of nondegradable Clb2, which is ex-
pressed both at high and low levels. In the presence of high 
doses, Clb2–Cdk has a double role: it both prevents cells from 
exiting mitosis and induces the release of Cdc14 (together 
with MEN, which is dispensable in this setting). This latter 
role is shared with Cdc5, with both of them being required for 
the release of Cdc14. When Cdc5 is degraded as a consequence 
of Cdc14 release and the ensuing APC/C
Cdh1 activation, Clb2–
Cdk cannot promote Cdc14 release alone, and thus the phos-
phatase goes back into the nucleolus. Nevertheless, Clb2–Cdk 
manages to block cells in mitosis, allowing Cdc5 to be synthe-
sized again and to subsequently induce a new round of Cdc14 
release  and  sequestration.  In  this  context,  Clb2–Cdk  likely 
plays an additional third role, promoting the transcription of 
Cdc5, that together with CLB2 is a member of the CLB2 clus-
ter genes, a set of 30 genes whose expression depends on Clb2 
(Darieva et al., 2003).
When the doses of nondegradable Clb2 are lowered, the 
presence of MEN becomes essential for full Cdc14 release 
Leaning on previous work (Queralt et al., 2006), we translated 
the two networks into mathematical models (Tables S1 and S2;   
and see supplemental equations). Simulations confirmed that 
both  networks  are  consistent  with  the  experimental  results 
(Figs. S4 and S5) and showed that the two models predict quite 
a different outcome if both Cdc5 and Cdc14 are inactivated   
after the initial release of Cdc14. According to the Cdc5 stabi-
lization hypothesis, Cdc14 should be resequestered and never 
released again in the double mutant because the stabilization 
of Cdc5 resulting from the lack of Cdc14 would be overcome 
by the inactivation of Cdc5 itself (Fig. 8 a). Contrarily, the 
Cfi1 dephosphorylation model predicts that Cdc14 would not 
be sequestered in a cdc5 cdc14 double mutant because if Cfi1 
phosphorylation could not be increased, neither could Cfi1 de-
phosphorylation (Fig. 8 b). In cells blocked in mitosis by high 
doses of Clb2, the single mutants, as expected, blocked the os-
cillations, with Cdc14 being constantly released in the cdc14-1 
strain and resequestered in the cdc5-as1 mutant (Fig. 8, c–e; 
Zhang et al., 2005). In agreement with the Cfi1 dephosphoryla-
tion hypothesis, when we performed the experiment in a strain 
carrying both of the cdc14-1 and cdc5-as1 alleles, we found 
that Cdc14 was not resequestered (Fig. 8 f). Interestingly, 
experimental data show that Cdc14 in the cdc14-1 cdc5-as1 
double mutant is constitutively released as much as in a simple 
cdc14-1 mutant, whereas simulations show a larger release 
in the latter case. The discrepancy might point to additional 
ways  by  which  Cdc14  induces  its  own  resequestration. We 
conclude that Cdc14 induces its own resequestration via ad-
ditional pathways besides the destabilization of Cdc5 mediated 
by APC/C
Cdh1.
Discussion
A two-hit model for Cdc14 release
Our results indicate that Clb–Cdk, Cdc5, and MEN, likely via 
kinase Dbf2, are important for Cdc14 activation, albeit to a dif-
ferent extent. Although Cdc5 is always required for an effective 
release of Cdc14, MEN and Clb–Cdk have partially overlap-
ping roles. Besides Clb2–Cdk, our data suggest that the S phase 
cyclin Clb5 contributes to Cdc14 release during early anaphase. 
The role of Clb5 in displacing and thus activating Cdc14, al-
though at odds with its well-known role of inhibitor of anaphase 
entry and progression (Shirayama et al., 1999; Jin et al., 2009), 
could underlie the mechanism whereby cells coordinate DNA 
replication with the completion of mitosis.
Based on the two-hit model, we can envision that during 
a normal cell cycle, Cdc5 cooperates with Clb–Cdk to induce 
the first release of Cdc14. At the metaphase to anaphase transi-
tion, Clb5 is degraded, shortly followed by a partial degrada-
tion  of  Clb2.  In  the  meantime,  MEN  becomes  active  and 
compensates for the inactivation of the two Clbs, making sure 
that either Clb–Cdk or MEN is always present throughout mi-
tosis to contribute to Cdc14 release. As Cdh1 is activated, Cdc5 
degradation causes the resequestration of Cdc14. If MEN is 
missing, the overall decrease in Clb2–Cdk and Clb5–Cdk activ-
ity may account for the shortened timing of Cdc14 release in 
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the initial release of Cdc14, after which it is degraded. Its pres-
ence is dispensable at high levels of stable Clb2, whereas it be-
comes essential when Clb2 is stabilized at low doses in the 
absence of MEN.
similarly to a normal cell cycle. As Cdh1 is activated, Cdc5   
degradation causes the resequestration of Cdc14 followed by   
MEN-driven cycles of Cdc14 release and sequestration. In both 
high and low doses of Clb2, the role of Clb5 is likely limited to 
Figure 8.  Cdc14 resequestration requires both Cdc5 inactivation and Cdc14 phosphatase activity. (a) The Cdc5 stabilization model predicts that Cdc14 is 
resequestered in the double mutant cdc14-1 cdc5-as1. Parameters and equations in the supplemental equations are shown in the text and Table S2, except 
for kph_cfi = 0, kdeph_cdh = 0, and kdeph_c5 = 0. (b) The Cfi1 dephosphorylation model predicts that when both Cdc5 and Cdc14 are not active, the phosphatase 
is not resequestered. Parameters and equations are shown in the supplemental equations paragraph and Table S1, except for kph_cfi = 0, kdeph_cdh = 0, and 
kdeph_cfi = 0. (c–f) GAL-CLB2dB (Ry1387; c), GAL-CLB2dB cdc14-1 (Ry1575; d), GAL-CLB2dB cdc5-as1 (cdc5L158G; Ry1607; e; Zhang et al., 2005; 
Snead et al., 2007), and GAL-CLB2dB cdc14-1cdc5-as1 (cdc5L158G; Ry1606; f) cells were arrested with 5 µg/ml -factor. After 3 h, cells were released 
into medium lacking pheromone supplemented with 1% galactose to induce the expression of Clb2. 180 min after the release, cells were shifted at 37°C 
and supplemented with 10 µM cdc5-as1 inhibitor (CMK; arrows; Snead et al., 2007). The percentages of cells with metaphase spindles (closed squares), 
anaphase spindles (closed circles), and cells with Cdc14 released from the nucleolus (open circles) were determined at the indicated times.JCB • VOLUME 190 • NUMBER 2 • 2010   220
once per cycle have evolved to an oscillatory regime, normally 
hidden by their coupling to the cell cycle machinery. The answer 
to this question is unknown but surely worth further investiga-
tions. In this study, we propose that an oscillatory dynamic guar-
antees a resetting of the molecular circuit to its initial conditions 
less dependent on the Cdk input than a simple negative feedback 
loop, thus avoiding intermediate outcomes of the circuit. In the 
case of Cdc14, that would be a state with only a fraction of Cdc14 
resequestered in the nucleolus at the end of mitosis, APC/C
Cdh1 
only partially active, and intermediate levels of Clb2. Such a con-
dition would leave cells in a state of unclear definition, partially 
mitosis and partially G1. The oscillatory dynamics, even if lim-
ited to one cycle, make sure that this fate is avoided.
Materials and methods
Yeast strains
All strains were derivatives of strain W303 (K699). In Table S3, the rele-
vant genotypes of the strains used in this study are indicated.
Growth conditions
Cell cycle arrest and synchronization experiments were performed as de-
scribed previously (Amon, 2002).
Cell cycle arrest experiments pertinent to Fig. 1. Cells were grown at 
23°C in yeast extract peptone (YEP) supplemented with 2% raffinose (YEPR) 
and arrested in G1 by adding 5 µg/ml of the -factor pheromone. For the 
G1 block experiments, when the arrest was complete (>90% unbudded 
cells), 2% galactose was added to drive the overexpression of the genes of 
interest. To maintain the G1 block, 1 h after galactose addition, 2.5 µg/ml 
-factor was readded to the media. For the S phase block experiments, 
when >90% of cells reached G1, cells were released into fresh YEPR sup-
plemented with 10 mg/ml HU to synchronously arrest them in the next   
S phase. When >90% of cells were arrested (cells have small- to medium-
size buds), 2% galactose and 5 µM of the 1NM-PP1 analogue 9 were 
added, respectively, to induce the overexpression of genes of interest and 
to inhibit ATP analogue–sensitive alleles when present.
Synchronization experiments pertinent to Fig.  2.  Cells  were  grown  at 
23°C in YEP supplemented with 2% glucose (YEPD) and arrested in G1 by 
adding 5 µg/ml of the -factor pheromone. When arrest was complete, cells 
were released in fresh YEPD media lacking the pheromone supplemented with 
5 µM of the 1NM-PP1 analogue 9 to inhibit the cdc15-as1 allele of CDC15.
Synchronization experiments pertinent to Fig. 4. MET3-CDC20 cells 
were grown in synthetic medium lacking methionine and arrested in G1 by 
adding 5 µg/ml of the -factor pheromone. When arrest was complete, cells 
were released in YEPD medium supplemented with 8 mM methionine to shut 
off the MET3 promoter in the presence or absence of 5 µM of the 1NM-PP1 
analogue 9.
Oscillation experiments
Cells were grown at 23°C in YEPR and arrested in G1 by adding 5 µg/ml 
of the -factor pheromone. When arrest was complete, cells were released 
in fresh YEPR media lacking the pheromone but with an added 1% galactose 
(YEPR + galactose high doses) or 0.05% galactose (YEPR + galactose low 
doses) to induce the expression of GAL-CLB2dB. Strains carrying temperature-
sensitive alleles were shifted at the restrictive temperature (37°C) after the 
majority of the population had undergone the metaphase to anaphase transi-
tion, as assessed by DAPI staining. The time of the shift for each experiment 
is indicated in Figs. 5–8 by an arrow. cdc15-as1 cells were inactivated by 
adding 5 µM Cdc15-as1 inhibitor (1NM-PP1 analogue 9) already at the 
time of release or as indicated in the legend of Fig. 8. cdc5-as1 cells were 
inactivated by adding 5 µM Cdc5-as1 inhibitor (CMK; Snead et al., 2007) 
after the majority of the population had reached anaphase, as assessed by 
DAPI staining.
Immunoblot analysis
Cells were lysed in 50 mM Tris, pH 7.5, 1 mM EDTA, 1 mM PNP, 50 mM 
DTT, 1 mM PMSF, and 2 µg/ml pepstatin with glass beads for 1 min and 
boiled in 1× sample buffer. Immunoblot analysis of the total amount of Clb2 
and Pgk1 was performed as described previously (Cohen-Fix et al., 1996) 
using -Clb2 (provided by A. Amon, Massachusetts Institute of Technology, 
We were surprised to observe that APC/C
Cdh1 was required 
for the oscillations in the presence of nondegradable Clb2. This   
result contrasts with the notion that Clb2–Cdk inhibits APC/C
Cdh1 
(Nasmyth, 1996). Similarly, Clb2–Cdk has been reported to in-
hibit MEN (König et al., 2010; for review see Stegmeier and 
Amon, 2004). In our system, however, MEN seems to be active 
even in the presence of high levels of stable Clb2. When we 
used the cfi1-6Cdk mutant, we found that oscillation raised in an 
MEN-dependent manner in the presence of active Clb2–Cdk- 
arresting cells in mitosis. At present, we cannot give an ex-
planation for these contrasting results. They possibly point to 
the fact that subcellular localization of the kinases and phos-
phatases, whose delicate balance controls Cdc14 localization, 
cannot be neglected if we aim to understand the network con-
trolling exit from mitosis.
Why oscillations?
Our  results  raise  the  problem  of  the  physiological  signifi-
cance  of  the  oscillations  of  Cdc14  localization.  We  believe 
that what we report contributes to the understanding of the 
principles underlying the coordination between the cell cycle 
engine (i.e., cyclin–Cdk activities) and the events triggered by 
the engine itself.
The oscillatory behavior reported in this study is not an 
isolated  example  but  resembles  other  cases  of  periodical   
phenotypes that emerge when the cell cycle engine is blocked. 
In budding yeast, the deletion of Clbs results in periodical bud-
ding in G1 (Haase and Reed, 1999). In both budding yeast and 
Drosophila melanogaster, the deletion or knockdown of M cy-
clins arrest cells before mitosis, but centrosomes nevertheless 
undergo  periodic  rounds  of  divisions  (Haase  et  al.,  2001;   
McCleland and O’Farrell, 2008). Mutants for three major con-
trol mechanisms preventing DNA rereplication can be blocked 
in G2/M with high levels of Clb2–Cdk and undergo multiple 
cycles of rereplication (Nguyen et al., 2001). These seemingly 
different systems share some basic properties among them-
selves and with our system: they are all triggered by the cell 
cycle engine and normally occur once per cell cycle. This last 
property is caused by their coupling with the cell cycle engine 
because, as we said, they show periodic behavior when the   
engine is blocked.
Do these systems also share properties at the molecular 
level? The molecular details of the circuits we have mentioned 
are not as well known as the circuit we analyzed in this study. 
However, their capability to oscillate implies that they all include 
at least one negative feedback loop. This fits very well with the 
need for these circuits to reset to their initial state after one cycle, 
ready for the forthcoming cell cycle. However, their capability   
to oscillate implies much stronger requirements than the simple 
negative feedback loop: they must have enough nonlinearity, 
sufficient time delays, and proper balancing of the rate constants, 
all conditions required for oscillations (Novák and Tyson, 2008). 
All of these conditions are not obvious, and indeed, the oscilla-
tory behavior in the presence of constant high levels of mitotic 
kinase came as a surprise.
Thus, we believe that an important question to be asked is 
why events coupled to the cell cycle engine that take place only 221 The mitotic exit oscillator at work • Manzoni et al.
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Cambridge, MA) and -Pgk1 (Invitrogen). Immunoblot analysis of the total 
amount of endogenous Cdc5 and Clb5 was performed according to the 
manufacturer’s guidelines using -Cdc5 and -Clb5 antibodies (Santa Cruz 
Biotechnology, Inc.) as described previously (Visintin et al., 2008).
Immunostaining
Indirect in situ immunofluorescence was performed as described previously 
(Visintin et al., 1999). Spindle formation and elongation was detected by   
-tubulin immunostaining with the YOL34 monoclonal antibody (AbD Serotec)   
followed  by  indirect  immunofluorescence  using  FITC-conjugated  anti–rat 
antibody (Jackson ImmunoResearch Laboratories, Inc.). Cdc14 immuno-
staining was performed using polyclonal Cdc14 antibodies (Santa Cruz 
Biotechnology, Inc.) followed by indirect immunofluorescence using CY3-
conjugated anti–goat antibody (Santa Cruz Biotechnology, Inc.). Nucleolar 
integrity was detected by -Nop1 (EnCor Biotechnology) immunostaining 
followed by indirect immunofluorescence using FITC-conjugated anti–mouse 
antibodies (Jackson ImmunoResearch Laboratories, Inc.).
Scoring of indirect immunofluorescence samples
Cell cycle progression was scored by analysis of spindle morphology. Spin-
dles were divided into three categories: (1) interphase microtubules, which in-
clude cells in the G1, S, and G2 phases of the cell cycle, (2) metaphase 
spindles, characteristic of cells in metaphase, and (3) anaphase spindles, 
which include cells in anaphase and telophase. Cdc14 was scored as seques-
tered when the large majority of the protein was inside the nucleolus, whereas 
it was considered released when the majority of the protein was outside the 
nucleolus. We did not distinguish between nuclear and cytoplasmic release; as 
soon as Cdc14 had left the nucleolus, we considered it released. This category 
also included cells containing a small amount of the phosphatase in the   
nucleolus. Examples of the aforementioned categories can be found in   
Visintin et al. (2008).
Images acquisition and analysis
Images of immunofluorescence were taken using either a microscope (IX81; 
Olympus) with a 60× 1.4 NA Plan Apo oil objective (Olympus) with an ad-
ditional enlargement of 1.6 (Fig. 2), a 100× 1.35 NA UPlan Apo oil objec-
tive (Olympus) with an additional enlargement of 1.6 (Fig. 3 and Fig. S3), 
or a microscope (BX51; Olympus) with a 60× 1.4 NA Plan Apo oil objective 
(Olympus) with an additional enlargement of 1.25 (Fig. S1). All images 
were acquired with a 12-bit camera (CoolSNAP; Photometrics). Analysis of 
the data was performed using MetaMorph software (version 7.5.6.0; MDS 
Analytical Technologies). No manipulations were performed other than 
adjustments in brightness and contrast.
Online supplemental material
Fig. S1 shows that the first release of Cdc14 is similar in wild-type cells and 
in cells expressing nondegradable Clb2. Fig. S2 contains controls pertinent 
to different experiments: Clb2 and Clb5 are stabilized in a MET-CDC20 
pds1 block, oscillations persist at 37°C, oscillations are lost when protein 
synthesis is inhibited, and oscillations persist in wild-type cells released from 
a nocodazole block but are abolished in a cdh1 mutant. Fig. S3 shows 
that the mutant Cdc14-1 protein can bind Cfi1 at the restrictive temperature.   
Fig. S4 shows simulations of the Cfi1 dephosphorylation model. Fig. S5 
shows simulations of the Cdc5 stabilization model. The Cfi1 dephosphoryla-
tion model equation paragraph includes all of the algebraic differential equa-
tions for the Cfi1 dephosphorylation model, whose parameters can be found 
in Table S1. The Cdc5 stabilization model equation paragraph includes all of 
the algebraic differential equations for the Cdc5 stabilization model, whose 
parameters can be found in Table S2. Table S3 contains a list of yeast strains 
used in this study. Videos 1 and 2 show the periodical localization of Cdc14 
in cells blocked in mitosis by high doses of nondegradable Clb2. Videos 3 
and 4 show that Cdc5 levels are reduced periodically when cells are blocked 
in mitosis by nondegradable Clb2. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201002026/DC1.
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